70 filings
Page 3 of 4
6-K
wo2y17hm
23 May 22
PolyPid Announces Recommendation by Data Safety Monitoring Board to Conclude Enrollment of
7:05am
6-K
m88able
11 May 22
PolyPid Provides Corporate Update and Reports First Quarter 2022 Financial Results
7:05am
6-K
1sqhmb zb1
3 May 22
Report of Foreign Private Issuer
6:17am
6-K
de1jkfyiz9mqn746lyvg
6 Apr 22
PolyPid Secures $15 Million Non-Dilutive Secured Term Loan Facility
8:36am
6-K
enrsrr77ll r7plvcpep
28 Mar 22
Notice of ANNUAL and EXTRAORDINARY General Meeting of shareholders
4:00pm
6-K
qgml9vn4k1630df8sby
2 Mar 22
PolyPid Announces 750th Patient Enrolled in SHIELD I Phase 3 Clinical
7:00am
6-K
nvvalhljny bapws01ml
9 Feb 22
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results
8:36am
6-K
4qnky vlw353hfqj0
3 Jan 22
PolyPid Announces Planned CEO Transition
8:00am
6-K
u41vyv 4e
18 Nov 21
PolyPid Announces 500th Patient Enrolled in SHIELD I Phase 3 Clinical Trial of D-PLEX100in Abdominal Surgery
7:00am
6-K
x6c6f38
10 Nov 21
PolyPid Ltd. Reports Third Quarter 2021 Financial Results and Provides Corporate Update
6:05am
6-K
52zi6zfi0wbof41
13 Sep 21
PolyPid Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in Brain Cancer
1:52pm
6-K/A
yki8l8xsw
30 Aug 21
Current report (foreign) (amended)
4:16pm
6-K
6h2jsbu2055jwgwxdo5
11 Aug 21
Report of Foreign Private Issuer
4:15pm
6-K
39zz6a7vnz6
11 Aug 21
PolyPid Ltd. Reports Second Quarter 2021 Financial Results and Provides Corporate Update
8:30am
6-K
gzrpais 9rwpcdba
2 Jul 21
Current Report
4:48pm
6-K
zfn3ga1djvr
2 Jul 21
Report of Foreign Private Issuer
2:26pm
6-K
qrpbzmfdly5n87fmhiq
19 May 21
PolyPid Announces Positive FDA Type B Meeting Feedback for D-PLEX100Development Program
6:01am
6-K
e580cq44adja
12 May 21
PolyPid Ltd. Reports First Quarter 2021 Financial Results and Provides Corporate Update
7:24am
6-K
f3dlk
4 May 21
Report of Foreign Private Issuer
4:05pm
6-K
ahj6it k4dplp
13 Apr 21
Report of Foreign Private Issuer
6:14am